Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs StoneX Group Inc. Common Stock (SNEX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs StoneX Group Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B), while StoneX Group Inc. Common Stock trades at $59.51 (market cap $7.23B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, StoneX Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and StoneX Group Inc. Common Stock for 0 Days on average.
| KYMR | SNEX | |
|---|---|---|
Market Cap | $8.88B | $7.23B |
Volume | 1,028,790 | 869,596 |
Sector | Health | Financials |
52-Week High | $127.31 | $92.67 |
52-Week Low | $55.80 | $37.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.27B | $28.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About StoneX Group Inc. Common Stock
StoneX Group Inc. is a financial services firm providing trading, clearing, execution, and cross-border payment services to institutional, commercial, and self-directed retail clients across global markets.
Read more on SNEX →
